Wimbledon Health Partners understands the root to detection of diseases such as multiple sclerosis and many others lie in diagnostic testing.
Boca Raton, FL (PRWEB) March 06, 2014
Wimbledon Health Partners, an on-site diagnostic testing company that provides physicians vascular, echocardiogram and electrodiagnostic testing with quality, state-of-the-art, in-office testing procedures recognizes MS Awareness Week. The detection and diagnosis of not only multiple sclerosis, but many other neurological and neuromuscular ailments are core to the services provided by NeuroRad Diagnostic Centers (NDC), the neurological arm of Wimbledon Health Partners.
NeuroRad Diagnostic Centers (NDC) offers a full range of diagnostic testing. Electrodiagnostic (EDX) tests are a series of electrical tests that examine various aspects of the neurological system. The most common of these tests are: Nerve Conduction Velocity Studies and Evoked Potentials. The Evoked Potential portion of the study is one of the various tests used to diagnosis multiple sclerosis.
According to the National MS Society, Multiple sclerosis (MS) involves an immune-mediated process in which an abnormal response of the body’s immune system is directed against the central nervous system (CNS), which is made up of the brain, spinal cord and optic nerves. The exact antigen — or target that the immune cells are sensitized to attack — remains unknown, which is why MS is considered by many experts to be "immune-mediated" rather than "autoimmune."
Wimbledon Health Partners Chief Executive Officer Mitchell Rubin stated, “Wimbledon Health Partners understands the root to detection of diseases such as multiple sclerosis and many others lie in diagnostic testing.”
Rubin went on to say, “Physicians look for common symptoms such as numbness or tingling, walking difficulties and pain to indicate if diagnostic testing may be medically necessary.”
About Wimbledon Health Partners:
Wimbledon Health Partners, a national on-site diagnostic testing organization with capabilities for diagnosing circulatory conditions that can be detected through the use of vascular ultrasound. Furthering their capabilities, nerve conduction velocity testing (NCV) is also utilized to support diagnosis of nerve involvement and manage risk. Wimbledon Health Partners is an innovative cooperative marketing and practice-enhancement program that provides physicians with the educational, compliance, and marketing tools necessary to provide quality, state-of-the-art, in-office testing procedures. For more information go to http://www.dxtesting.com or call 855-200-VCOA (8262).